Trial Outcomes & Findings for Walking Aids in the Management of Hip Osteoarthritis (NCT NCT00506714)
NCT ID: NCT00506714
Last Updated: 2012-10-04
Results Overview
Recruitment status
COMPLETED
Study phase
NA
Target enrollment
26 participants
Primary outcome timeframe
Baseline
Results posted on
2012-10-04
Participant Flow
Participant milestones
| Measure |
Group 1
Healthy adults
|
Group 2
Adults with symptomatic hip osteoarthritis
|
|---|---|---|
|
Overall Study
STARTED
|
13
|
13
|
|
Overall Study
COMPLETED
|
13
|
13
|
|
Overall Study
NOT COMPLETED
|
0
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Walking Aids in the Management of Hip Osteoarthritis
Baseline characteristics by cohort
| Measure |
Group 1
n=13 Participants
Healthy adults
|
Group 2
n=13 Participants
Adults with symptomatic hip osteoarthritis
|
Total
n=26 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Categorical
<=18 years
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
6 Participants
n=5 Participants
|
5 Participants
n=7 Participants
|
11 Participants
n=5 Participants
|
|
Age, Categorical
>=65 years
|
7 Participants
n=5 Participants
|
8 Participants
n=7 Participants
|
15 Participants
n=5 Participants
|
|
Age Continuous
|
65 years
STANDARD_DEVIATION 4.4 • n=5 Participants
|
67 years
STANDARD_DEVIATION 5.9 • n=7 Participants
|
66 years
STANDARD_DEVIATION 5.2 • n=5 Participants
|
|
Sex: Female, Male
Female
|
2 Participants
n=5 Participants
|
2 Participants
n=7 Participants
|
4 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
11 Participants
n=5 Participants
|
11 Participants
n=7 Participants
|
22 Participants
n=5 Participants
|
|
Region of Enrollment
United States
|
13 participants
n=5 Participants
|
13 participants
n=7 Participants
|
26 participants
n=5 Participants
|
PRIMARY outcome
Timeframe: BaselinePopulation: Analysis was per protocol
Outcome measures
| Measure |
Group 1
n=13 Participants
Healthy adults walking without a cane at baseline
|
Group 2
n=13 Participants
Adults with symptomatic hip osteoarthritis walking without a cane at baseline
|
|---|---|---|
|
Gait Velocity
|
107.5 cm/s
Standard Deviation 14.3
|
79.7 cm/s
Standard Deviation 9.9
|
SECONDARY outcome
Timeframe: BaselinePopulation: Analysis was per protocol
Measured gait velocity when hip OA subjects walked with a cane at the baseline visit.
Outcome measures
| Measure |
Group 1
n=13 Participants
Healthy adults walking without a cane at baseline
|
Group 2
Adults with symptomatic hip osteoarthritis walking without a cane at baseline
|
|---|---|---|
|
Gait Velocity With a Cane in Hip OA Subjects
|
68.7 cm/s
Standard Deviation 15.4
|
—
|
SECONDARY outcome
Timeframe: 4 weeksPopulation: Analysis was per protocol
Gait velocity when adults with symptomatic hip osteoarthritis walked with a cane after four weeks of cane use
Outcome measures
| Measure |
Group 1
n=13 Participants
Healthy adults walking without a cane at baseline
|
Group 2
Adults with symptomatic hip osteoarthritis walking without a cane at baseline
|
|---|---|---|
|
Gait Velocity
|
74.5 cm/s
Standard Deviation 14.2
|
—
|
Adverse Events
Group 1
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Group 2
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place